Adult Acute Myeloid Leukemia research hub

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

This study is testing a new medicine, mocravimod, for adults with a type of blood cancer called AML who are having a stem cell transplant. It aims to see if mocravimod can help prevent the cancer from coming back and improve treatment success.